We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$2.82B
AUM Growth
-$1.18B
Cap. Flow
-$1.3B
Cap. Flow %
-46.06%
Top 10 Hldgs %
18.63%
Holding
1,492
New
367
Increased
132
Reduced
283
Closed
515

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.4M
2
AMGN icon
Amgen
AMGN
+$7.87M
3
MRNA icon
Moderna
MRNA
+$6.95M
4
PDD icon
Pinduoduo
PDD
+$5.73M
5
BAC icon
Bank of America
BAC
+$4.82M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$35.8M
2
BIIB icon
Biogen
BIIB
+$9.49M
3
AON icon
Aon
AON
+$6.72M
4
RUN icon
Sunrun
RUN
+$4.78M
5
PARA
Paramount Global Class B
PARA
+$4.32M

Sector Composition

Rank Sector Weight
1 Healthcare 2.27%
2 Communication Services 1.3%
3 Consumer Discretionary 1.21%
4 Technology 1.07%
5 Financials 0.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
1026
CALL
BioCryst Pharmaceuticals
BCRX
$2.42B
-30,000
Closed -$305K
BCRX icon
1027
PUT
BioCryst Pharmaceuticals
BCRX
$2.42B
-30,000
Closed -$305K
BCS icon
1028
Barclays
BCS
$87.8B
-45,000
Closed -$460K
BE icon
1029
CALL
Bloom Energy
BE
$48.2B
-900
Closed -$24K
BEPC icon
1030
Brookfield Renewable
BEPC
$5.86B
-12,500
Closed -$585K
BEPC icon
1031
PUT
Brookfield Renewable
BEPC
$5.86B
-25,000
Closed -$1.17M
BIDU icon
1032
Baidu
BIDU
$35.7B
-15,000
Closed -$3M
BIDU icon
1033
PUT
Baidu
BIDU
$35.7B
-124,000
Closed -$27M
BIIB icon
1034
Biogen
BIIB
$30.9B
-31,330
Closed -$9.49M
BILI icon
1035
CALL
Bilibili
BILI
$7.75B
-15,000
Closed -$1.61M
BILI icon
1036
Bilibili
BILI
$7.75B
-18,000
Closed -$1.95M
SRTA
1037
CALL
Strata Critical Medical Inc
SRTA
$421M
-80,100
Closed -$824K
BLK icon
1038
CALL
Blackrock
BLK
$167B
-7,500
Closed -$5.66M
BLK icon
1039
PUT
Blackrock
BLK
$167B
-1,000
Closed -$754K
BLUE
1040
CALL
DELISTED
bluebird bio
BLUE
-1,089
Closed -$425K
BLUE
1041
PUT
DELISTED
bluebird bio
BLUE
-2,455
Closed -$959K
BMY icon
1042
CALL
Bristol-Myers Squibb
BMY
$129B
-18,500
Closed -$1.17M
BMY icon
1043
Bristol-Myers Squibb
BMY
$129B
-250
Closed -$16.3K
BNED icon
1044
Barnes & Noble Education
BNED
$435M
-35
Closed -$28K
BNED icon
1045
PUT
Barnes & Noble Education
BNED
$435M
-100
Closed -$81K
BNTX icon
1046
BioNTech
BNTX
$23.5B
-1,000
Closed -$109K
BNTX icon
1047
PUT
BioNTech
BNTX
$23.5B
-7,600
Closed -$830K
BRK.B icon
1048
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
-15,600
Closed -$3.98M
BSM icon
1049
PUT
Black Stone Minerals
BSM
$3.14B
-4,000
Closed -$35K
BXMT icon
1050
CALL
Blackstone Mortgage Trust
BXMT
$2.77B
-50,000
Closed -$1.55M

Similar funds

SG3 Management's Q2 2021 Portfolio in Review

As of Q2 2021, SG3 Management held 1,492 positions worth $2.82B, down 30% from $4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

SG3 Management withdrew a net $1.3B in Q2 2021, closing 515 positions and reducing 283 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $35.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.3% of assets, up from 1.8% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, SG3 Management opened a new position in Alphabet (Google) Class A worth $24.4M.

  • SG3 Management's largest Q2 2021 buy was Alphabet (Google) Class A: 200,000 shares worth $24.4M.
  • SG3 Management added most to Pinduoduo in Q2 2021, an estimated $5.73M increase.
  • SG3 Management's biggest Q2 2021 reduction was Paramount Global Class B, cutting an estimated $4.32M.
  • SG3 Management fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $35.8M.
  • SG3 Management's ten largest holdings make up 19% of its $2.82B portfolio in Q2 2021.
  • SG3 Management opened 367 new positions and closed 515 in Q2 2021.
  • SG3 Management's portfolio value fell 30% quarter-over-quarter to $2.82B.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.